Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $97.6300 (5.11%) ($92.0300 - $98.1100) on Fri. Apr. 24, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.12% (three month average) | RSI | 84 | Latest Price | $97.6300(5.11%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.8% a day on average for past five trading days. | Weekly Trend | LGND advances 9.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(55%) IWO(53%) XBI(51%) IWC(48%) IWM(48%) | Factors Impacting LGND price | LGND will decline at least -3.06% in a week (0% probabilities). VIXM(-25%) UUP(-17%) VXX(-16%) UNG(-2%) TLT(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.06% (StdDev 6.12%) | Hourly BBV | 0 () | Intraday Trend | 4.2% | | | |
|
5 Day Moving Average | $96.22(1.47%) | 10 Day Moving Average | $93.48(4.44%) | 20 Day Moving Average | $84.76(15.18%) | To recent high | -9.5% | To recent low | 54.1% | Market Cap | $1.569b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |